BZYR OTC
Burzynski Research Institute, Inc.
1W: +0.0%
1M: +25.0%
3M: -50.0%
YTD: -90.0%
1Y: -94.9%
3Y: -97.1%
5Y: -93.1%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.3M
52W Range0.001-0.047
Volume60,000
Avg Volume26,299
Beta0.38
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOStanislaw R. Burzynski
Employees1
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date1997-01-02
Websitepropcitweb.ddns.net:83
9432 Katy Freeway
Houston, TX 77055
US
Houston, TX 77055
US
713 335 5697
About Burzynski Research Institute, Inc.
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Latest News
No recent news
Recent Insider Trades
No insider trades found